The EU Medical Device Regulation (MDR) categorises drug-device combinations based on their primary mode of action (PMOA). The regulatory pathway is determined by whether the product is primarily a medicinal product (drug) or a medical device. In this blog, we will...
Navigating EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) is proving to be one of the most complex regulatory challenges for manufacturers. We have presented some of the common EU MDR compliance challenges. Additionally, we have provided...
Common EU MDR pitfalls are recurring mistakes and compliance gaps that medical device manufacturers encounter when implementing EU MDR. These compliance gaps frequently lead to delays in obtaining CE marking, and rejection by Notified Bodies. The transition from the...
Legacy devices are products that were legally certified under older directives (MDD) but are allowed to remain in EU market. The EU MDR has released new guidelines for legacy devices. Legacy devices will have to mandatorily comply with these guidelines to...
You cannot copy content of this page
Contact Us!
Chat with Us on WhatsApp! We reply within 5 minutes!